Alteration of caspases and other apoptosis regulatory proteins in Down syndrome

  • T. Gulesserian
  • E. Engidawork
  • B. C. Yoo
  • N. Cairns
  • G. Lubec


Apoptosis has been implicated in the selective neuronal loss of Down syndrome (DS). Apoptosis activates a family of cysteine proteases with specificity for aspartic acid residues referred to as caspases that play a key role in dismantling a cell committed to die. Caspase activity is regulated by a variety of proteins that possess a domain resembling the prodomains of caspases. Little is known, however, about the changes of caspases and their regulatory proteins in DS. Here, we investigated levels of nine such different proteins by western blot technique in frontal cortex and cerebellum of control and DS subjects. The protein levels of DFF45 (DNA fragmentation factor 45), and FLIP (FADD like interleukin-lß-converting enzyme inhibitory proteins) were significantly decreased whereas that of RICK (RIP-like interacting CLARP kinase) increased in both regions of DS. In contrast, cytochrome c, Apaf-1 (apoptosis protease activating factor-1), procaspase-9 and ARC (apoptosis repressor with caspase recruitment domain) were unchanged. Procaspase-3 and -8 were significantly decreased in frontal cortex but no significant change was observed in cerebellum. Regression analysis revealed no correlation between postmortem interval and levels of the investigated proteins. However, inconsistent correlation was found between age and levels of proteins as well as amongst the density of individual proteins.


Frontal Cortex Down Syndrome Postmortem Interval Death Effector Domain Caspase Recruitment Domain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 proteases nomenclature. Cell 87: 171PubMedCrossRefGoogle Scholar
  2. Anderson AJ, Stoltzner S, Lai F, Su J, Nixon RA (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer’s disease, and effect of postmortem tissue archival on tunnel. Neurobiol Aging 21: 511–524PubMedCrossRefGoogle Scholar
  3. Bambrick LL, Krueger BK (1999) Neuronal apoptosis in mouse trisomy 16: mediation by caspases. J Neurochem 72: 1769–1772PubMedCrossRefGoogle Scholar
  4. Becher B, Barker PA, Owens T, Antel PJ (1998) CD95-CD95L: can the brain learn from the immune system? Trends Neurosci 21: 114–117PubMedCrossRefGoogle Scholar
  5. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, Weissberg P (1998) Cell surface trafficking of Fas: a rapid mechanism of p53 mediated apoptosis. Science 282: 290–293PubMedCrossRefGoogle Scholar
  6. Busciglio J, Yanker BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779PubMedCrossRefGoogle Scholar
  7. Castagne V, Gautschi M, Lefevre K, Posada A, Clarke PG (1999) Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59: 397–423PubMedCrossRefGoogle Scholar
  8. Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, Anderson K (1997) Cytochrome c dependent and independent induction of apoptosis in multiple myeloma cells. J Biol Chem 272: 29995–29997PubMedCrossRefGoogle Scholar
  9. Chinnaiyan AM, Dixit VM (1996) The cell death machine. Curr Biol 6: 555–562PubMedCrossRefGoogle Scholar
  10. Chinnaiyan AM, O’Rourke K, Lane BR, Dixit VM (1997) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275: 1122– 1126PubMedCrossRefGoogle Scholar
  11. Chua BT, Guo K, Li P (2000) Direct cleavage by the calcium activated protease calpain can lead to inactivation of caspases. J Biol Chem 275: 5131–5135PubMedCrossRefGoogle Scholar
  12. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326: 1–16PubMedGoogle Scholar
  13. Cryns V, Yuan J (1998) Proteases to die for. Gene Dev 12: 1551–1570PubMedCrossRefGoogle Scholar
  14. de la Monte SM, Sohn YK, Ganju N, Wands JR (1998) p53 and CD95 associated apoptosis in neurodegenerative disorders. Lab Invest 78: 401–411PubMedGoogle Scholar
  15. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383–424PubMedCrossRefGoogle Scholar
  16. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43–50PubMedCrossRefGoogle Scholar
  17. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D (1997) CASH, a novel caspase homologue with death effector domains. J Biol Chem 272: 19641–19644PubMedCrossRefGoogle Scholar
  18. Hennino A, Berard M, Casmayor-Palleja M, Krammer PH, Defrance T (2000) Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells. J Immunol 165: 3023–3030PubMedGoogle Scholar
  19. Hofman K, Bucher P, Tschopp J (1997) The CARD domain: a new apoptotic signaling motif. Trends Biochem Sci 22: 155–156CrossRefGoogle Scholar
  20. Holinger EP, Chittenden T, Lutz RJ (1999) Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J Biol Chem 274: 13298–13304PubMedCrossRefGoogle Scholar
  21. Inohara N, del Peso L, Koseki T, Chen S, Nunez G (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem 273: 12296–12300PubMedCrossRefGoogle Scholar
  22. Inohara N, Koseki T, Hu Y, Chen S, Nunez G (1997) CLARP, a death effector domain containing protein interacts with caspase-8 and regulates apoptosis. Proc Natl Acad Sci USA 94: 10717–10722PubMedCrossRefGoogle Scholar
  23. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195PubMedCrossRefGoogle Scholar
  24. Ito A, Uehara T, Tokumitsu AI, Okuma Y, Nomura Y (1999) Possible involvement of cytochrome c release and sequential activation of caspases in ceramide induced apoptosis in SK-N-MC cells. Biochim Biophys Acta 1452: 263–274PubMedCrossRefGoogle Scholar
  25. Ivins KJ, Thornton PL, Rohn TT, Cotman CW (1999) Neuronal apoptosis induced by ß-amyloid is mediated by caspase-8. Neurobiol Dis 6: 440–449PubMedCrossRefGoogle Scholar
  26. Jänicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357–9360PubMedCrossRefGoogle Scholar
  27. Katoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M,Kennedy N, Kvacsovics M, Tschopp J (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kB and Erk signaling pathways. Curr Biol 10: 640–648CrossRefGoogle Scholar
  28. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA,Perry G, Whithouse PJ, Taniguchi T (1998) Alterations of proteins regulating apoptosis. Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1, and CPP32, in Alzheimer’s disease.Brain Res 780: 260–269PubMedCrossRefGoogle Scholar
  29. Koseki T, Inohara N, Chen S, Nunez G (1998) ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA 95: 5156–5160PubMedCrossRefGoogle Scholar
  30. Lee SA, Zheng TS, Flavell RA, Rakic P, Roth KA (2000) Amyloid beta induced neuronal death is Bax dependent but caspase independent. J Neuropathol Exp Neurol 4: 271–279Google Scholar
  31. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmed M, Alnemri ES, Wang X (1997) Cytochrome c and dATP dependent formation of Apaf-1/caspase-9 complex initiates an apoptosis cascade. Cell 91: 479–489PubMedCrossRefGoogle Scholar
  32. Liu W, kato M, Akhand AA, Hayakawa A, Suzuki H, Miyata T, Kurokawa K, Hotta Y,Ishikawa N, Nakashima I (2000) 4-Hydroxynonenal induces a cellular redox status related activation of the caspase cascade for apoptotic cell death. J Cell Sci 113: 635–641PubMedGoogle Scholar
  33. Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175–184PubMedCrossRefGoogle Scholar
  34. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362: 847–849PubMedCrossRefGoogle Scholar
  35. Mattson MP, Partin J, Begley JG (1998) Amyloid β peptide induces apoptosis related events in synapses and dendrites. Brain Res 807: 167–176PubMedCrossRefGoogle Scholar
  36. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Wiber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer P (1998) p53 activates the CD95 gene in response to DNA damage by anticancer drugs. J Exp Med 188: 2033–2045PubMedCrossRefGoogle Scholar
  37. Nicholson DW, Thornberry NA (1998) Caspases: killer proteases. Trends Biochem Sci 22: 299–306CrossRefGoogle Scholar
  38. Nunez G, Benedict MA, Hu Y, Inohara N (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237–3245PubMedCrossRefGoogle Scholar
  39. Pellegrini L, Passer BJ, Tabaton M, Ganjei JK, D’Adamio L (1999) Alternative, non-secretase processing of Alzheimer’s ß-amyloid precursor protein during apoptosis by caspase-6 and -8. J Biol Chem 274: 21011–21016PubMedCrossRefGoogle Scholar
  40. Peter ME, Krammer PH (1998) Mechanism of CD95 (APO-1/Fas) mediated apoptosis.Curr Opin Immunol 10: 545–551PubMedCrossRefGoogle Scholar
  41. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53 induced apoptosis. Nature 389: 300–305PubMedCrossRefGoogle Scholar
  42. Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99–104PubMedCrossRefGoogle Scholar
  43. Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941–2953PubMedGoogle Scholar
  44. Saleh A, Srinivasula SM, Acharya S, Fishel R, Alnemri ES (1999) Cytochrome c and dATP mediated oligomerization of Apaf-1 is a prerequisite for proscaspase-9 activation. J Biol Chem 274: 17941–17945PubMedCrossRefGoogle Scholar
  45. Seidl R, Fang-Kircher S, Bidmon B, Cairns N, Lubec G (1999) Apoptosis associated proteins p53 and APO-1/FAS (CD95) in brains of adult patients with Down syndrome. Neurosci Lett 260: 9–12PubMedCrossRefGoogle Scholar
  46. Shimohama S, Tanino H, Fujimoto S (1999) Changes in caspase expression in Alzheimer’s disease: comparison with development and aging. Biochem Biophys Res Commun 256: 381–384PubMedCrossRefGoogle Scholar
  47. Shu HB, Halpin DR, Goeddel DV (1997) Casper is a FADD and caspase related inducer of apoptosis. Immunity 6: 751–763PubMedCrossRefGoogle Scholar
  48. Srinivasula SM, Ahmad M, Ottilie S et al. (1997) FLAME-1, a novel FADD like antiapoptotic molecule that regulates Fas/TNFR-1 induced apoptosis. J Biol Chem 272: 18542–18545PubMedCrossRefGoogle Scholar
  49. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462PubMedCrossRefGoogle Scholar
  50. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312–1322PubMedCrossRefGoogle Scholar
  51. Vogt M, Bauer MK, Ferrari D, Schulze-Osthoff K (1998) Oxidative stress and hypoxia/ reoxygenation triggers CD95 (APO-1/Fas) ligand expression in microglial cells. FEBS Lett 429: 67–72PubMedCrossRefGoogle Scholar
  52. Wellington CL, Hayden MR (2000) Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin Genet 57: 1–10PubMedCrossRefGoogle Scholar
  53. Wu D, Wallen HD, Inohara N, Núñez G (1997) Interaction and regulation of Caenorhabditis elegans death protease CED-3 by CED-4 and CED-9. J Biol Chem 272: 21449–21454PubMedCrossRefGoogle Scholar
  54. Zhivotovsky B, Samali A, Gahm A, Orrenius S (1999) Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ 6: 644–651PubMedCrossRefGoogle Scholar
  55. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c dependent activation of caspase-3. Cell 90: 405–413PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2001

Authors and Affiliations

  • T. Gulesserian
    • 1
  • E. Engidawork
    • 1
  • B. C. Yoo
    • 1
  • N. Cairns
    • 2
  • G. Lubec
    • 1
  1. 1.Department of PediatricsUniversity of ViennaViennaAustria
  2. 2.Department of Neuropathology, Institute of PsychiatryKing’s CollegeLondonUK

Personalised recommendations